Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cybin Inc (NY: CYBN ) 0.2640 -0.0006 (-0.23%) Official Closing Price Updated: 4:10 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Cybin Inc < Previous 1 2 ... 14 15 16 17 18 19 20 21 Next > Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up? October 23, 2021 The psychedelic drug industry is advancing by leaps and bounds, but the stocks have been sliding. Why this disconnect won't last. Via Talk Markets Psychedelics Discussed At Benzinga Cannabis Capital Conference: Growth Opportunities, Mental Health & Pharma October 19, 2021 Ronan Levy, co-founder and executive chairman of Field Trip Ltd (NASDAQ: FTRP), a company developing a network of psychedelics-assisted therapy clinics; Doug Drysdale, CEO,... Via Benzinga Topics Cannabis Exposures Cannabis Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation October 18, 2021 The Week In Psychedelics Via Benzinga This Psychedelics Stock Could Grow 300% In One Year August 26, 2021 Cantor Fitzgerald initiated coverage of Cybin (NYSE: Via Benzinga Forget The Hype: The Psychedelic Stocks Sector Went Down In The Third Quarter Of 2021 October 15, 2021 Despite the prevailing hype, the psychedelic sector went down considerably last quarter (July through September) and has gone down even further so far this month. Via Talk Markets There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are October 13, 2021 Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... Via Benzinga 6 Psychedelic Stocks With Buy Rating: Why Are They Good Investments? October 01, 2021 This article by Jason Najum was originally published on Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021 October 05, 2021 Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ: Via Benzinga Four Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference September 30, 2021 The healthcare sector is booming and startups are the driving force behind the innovations that will affect the future of life on earth. ... Via Benzinga The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio? September 21, 2021 We compare and contrast the three psychedelic drug ETFs and assess which investor needs each addresses. Via Talk Markets Cannabis Drug Stocks Have Mirrored Performance Of Psychedelic Drug Stocks To Date In September September 20, 2021 Which index has outperformed so far in September, the Pure-Play Marijuana-Based Drug Stocks Index or the Pure-Play Psychedelic Compounds-Based Drug Stocks Index? Via Talk Markets Topics Cannabis Exposures Cannabis 38 Stocks Moving In Thursday's Mid-Day Session September 16, 2021 Gainers IronNet Cybersecurity, Inc. (NASDAQ: IRNT) shares jumped 30.4% to $41.90 amid increased retail investor interest in the stock on social media. Dutch Bros Inc. (NYSE: BROS... Via Benzinga Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry? September 09, 2021 By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate... Via Benzinga Marijuana Vs. Psychedelic Drug Stocks: Which Out-Performed Last Week? September 06, 2021 The Marijuana & Psychedelic Compounds-Based Drug Stocks Index consists of 8 constituents in each of two sub-categories, let's see which out-performed last week. Via Talk Markets Topics Cannabis Exposures Cannabis Buying Cybin Stock Right Now Could Be a Brilliant Move September 02, 2021 You'll need to be prepared for a long holding period and a hearty helping of risk. Via The Motley Fool Topics Law Enforcement Exposures Legal Psychedelic Drug Industry Report Card For 2021 September 01, 2021 In assessing the psychedelic drug industry, a primary focus for investors is drug development. Via Talk Markets 48 Biggest Movers From Yesterday August 31, 2021 Gainers RenovoRx, Inc. (NASDAQ: RNXT) climbed 107.8% to close at $16.02 on Monday after the company was granted FDA clearance for ‘Catheter, Intravascular Occluding,... Via Benzinga Exposures Product Safety 35 Stocks Moving In Monday's Mid-Day Session August 30, 2021 Gainers Globalstar, Inc. (NYSE: GSAT) shares climbed 43.6% to $2.0535. GSAT shares traded higher following a note sent out by popular Apple Inc. (NASDAQ: AAPL) analyst Ming... Via Benzinga Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold August 30, 2021 Contents Via Benzinga Magic Mushroom Drug Stock Performances YTD August 29, 2021 Of the 35 companies involved in clinical stage research of psychedelic substances, 20 are researching the benefits of psilocybin, the primary psychoactive ingredient in “magic mushrooms”. Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021 August 26, 2021 Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE: Via Benzinga Cybin Inc. (NEO: CYBN) (NYSE: CYBN) Files Two International Patent Applications In Support Of The Company's Research Phase Programs August 19, 2021 Cybin (NEO: CYBN) (NYSE: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed two additional international patent applications; these... Via Benzinga Topics Intellectual Property Exposures Intellectual Property Psyched: Cybin Debuts On NYSE, Nonprofits In Psychedelics Space Reach New Milestones, Filament Receives Psilocybin Patent August 10, 2021 Cybin Debuts On The NYSE Last week, Cybin (NYSE:CYBN... Via Benzinga Cybin Becomes First Psychedelics Company On The NYSE: CEO Explains Everything You Need To Know August 05, 2021 Cybin (NYSE:CYBN), a biotech company in the psychedelics spa... Via Benzinga < Previous 1 2 ... 14 15 16 17 18 19 20 21 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.